Bi-profenid contains ketoprofen, a nonsteroidal anti-inflammatory drug, and is registered in 15 countries spread across Latin America, Eastern Europe, the Caucasus, and the Eastern Mediterranean. The brand sits within the broad family of NSAID analgesics that international travellers will recognise by therapeutic role even when the specific name on the box is unfamiliar.
Ketoprofen is used in the management of pain and inflammation across a range of clinical situations — including post-surgical pain, dental and oral conditions such as gingivitis and stomatitis, throat conditions such as laryngitis, neuralgia, and joint disease including osteoarthritis and rheumatoid arthritis. The structured indication list further down this page details the registered uses recognised by the regulators in the markets where Bi-profenid is sold.
The country footprint is geographically scattered rather than concentrated in a single region. Markets where Bi-profenid is registered include Mexico, Poland, Egypt, Peru, and Turkey, and a traveller moving between these jurisdictions may encounter the same brand on pharmacy shelves. Outside this list, the brand itself is unlikely to appear, although ketoprofen as a molecule is widely distributed worldwide under a number of other commercial names, both as systemic preparations and as topical products for joint and muscular pain.
Other medications within the broader NSAID class are sold in nearly every regulated market, and a pharmacist in the destination country can identify a locally registered ketoprofen product or an appropriate alternative in the same class. Decisions about starting, stopping, or switching an NSAID — particularly for ongoing arthritic or inflammatory conditions — belong with a healthcare provider familiar with the patient's medical background.
